Key facts
- It has raised $11.3M; the latest was Accelerator/Incubator in Mar 2025.
- Notable investors include Mitsubishi UFJ Capital, Mizuho Capital, Japan External Trade Organization, Resona Capital, DBJ Capital — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Algal Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Algal Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Algal Bio
Operator of an algae-related laboratory intended to clarify the functionality of microalgae as food ingredients. The company works on combining different technologies and know-how such as an intensive alga strain library multiplied with diverse screening and cultivating technologies and has built a very unique algae bio-foundry platform for applying algae in all industries and applications to combat three major global issues which are: increasing health consciousness in, food crisis, and global warming.
- Sector
- Business Products and Services (B2B)
- HQ
- Kashiwa, Japan
- Founded
- 2018
- Employees
- 50
- Website
- algalbio.co.jp/
- Ownership
- Privately Held (backing)
Algal Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Algal Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Algal Bio in its N-PORT filings yet. We sweep new filings monthly.